N-(4-((2S,4R)-4-(2-((S)-1-((2S,4R)-4-hydroxy-2-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethylcarbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-ylamino)-2-oxoethoxy)-2-methylpiperidin-1-yl)-2-methoxyphenyl)-6-(1H-pyrazol-5-yl)picolinamide

ID: ALA4790381

Chembl Id: CHEMBL4790381

PubChem CID: 162669079

Max Phase: Preclinical

Molecular Formula: C47H57N9O7S

Molecular Weight: 892.10

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(N2CC[C@@H](OCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@@H](C)c3ccc(-c4scnc4C)cc3)C(C)(C)C)C[C@@H]2C)ccc1NC(=O)c1cccc(-c2ccn[nH]2)n1

Standard InChI:  InChI=1S/C47H57N9O7S/c1-27-21-34(18-20-55(27)32-15-16-37(40(22-32)62-7)52-44(59)38-10-8-9-35(51-38)36-17-19-49-54-36)63-25-41(58)53-43(47(4,5)6)46(61)56-24-33(57)23-39(56)45(60)50-28(2)30-11-13-31(14-12-30)42-29(3)48-26-64-42/h8-17,19,22,26-28,33-34,39,43,57H,18,20-21,23-25H2,1-7H3,(H,49,54)(H,50,60)(H,52,59)(H,53,58)/t27-,28-,33+,34+,39-,43+/m0/s1

Standard InChI Key:  ITIRIVDRAPMHII-LHJQLXEHSA-N

Alternative Forms

  1. Parent:

    ALA4790381

    ---

Associated Targets(Human)

IRAK1 Tchem VHL/IRAK1 (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 892.10Molecular Weight (Monoisotopic): 891.4102AlogP: 5.91#Rotatable Bonds: 14
Polar Surface Area: 204.00Molecular Species: NEUTRALHBA: 12HBD: 5
#RO5 Violations: 3HBA (Lipinski): 16HBD (Lipinski): 5#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.39CX Basic pKa: 3.69CX LogP: 3.61CX LogD: 3.60
Aromatic Rings: 5Heavy Atoms: 64QED Weighted: 0.09Np Likeness Score: -1.04

References

1. Kargbo RB.  (2021)  Targeting IRAK1 for Degradation with PROTACs.,  12  (6.0): [PMID:34141074] [10.1021/acsmedchemlett.1c00244]

Source